| Literature DB >> 35387191 |
Huan Chen1, Tao Peng1, Hanle Shang1, Xianglong Shang1, Xianghui Zhao1, Mingren Qu1, Xiaozhen Song1.
Abstract
To investigate the effect of Puerarin on intramuscular fat deposition in heat-stressed beef cattle and its underlying mechanism. Thirty-two healthy Jinjiang bulls were randomly divided into four groups and dietary with 0 (Control), 200 (Pue200), 400 (Pue400), and 800 (Pue800) mg/kg Puerarin in the feed concentrate. The results showed that Puerarin treatment enhanced the concentration of crude fat, fatty acid (C14:1 and C17:1), and the activity of fatty acid synthase in Longissimus thoracis (LT), but decreased the levels of blood leptin (P < 0.05). High-throughput sequencing of mRNA technology (RNA-Seq) was used and the analysis showed that 492 genes were down-regulated and 341 genes were up-regulated in LT, and these genes were significantly enriched to the pathways related to lipid metabolism. These results indicated that dietary supplemental with Puerarin enhanced intramuscular fat deposition by regulating lipid metabolism of heat-stressed beef cattle.Entities:
Keywords: RNA-seq; beef cattle; heat stress; intramuscular fat deposition; lipid metabolism; puerarin
Year: 2022 PMID: 35387191 PMCID: PMC8978796 DOI: 10.3389/fnut.2022.817557
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Composition and nutrient levels of the basal diet (air-dry basis, %).
| Ingredients | Content | Nutrient levels | Content |
| Wheat | 56.50 | DM | 89.42 |
| NaCl | 0.50 | NE | 5.45 |
| NaHCO3 | 1.00 | CP | 11.19 |
| Premix | 2.00 | NDF | 30.08 |
| Rice straw | 20.00 | ADF | 15.18 |
| Brewer’s grains | 20.00 | Ash | 7.80 |
| Amount | 100.00 | Ca | 1.11 |
| P | 0.67 |
Oligonucleotide primers used for quantitative real-time PCR.
| Gene name | PrimerName | Sequence (5′-3′) |
| FABP3 | FABP3-F | TGGAGTCGAGTTCGATGAG |
| FABP3-R | TTTCCCGCACAAGTGATGTC | |
| ACSL1 | ACSL1-F | TACGAAGGCTACGGACAGAC |
| ACSL1-R | CCTTGGCAGCCAGGTAATTC | |
| SCD | SCD-F | AGCTGAGAAGCTGGTGATGT |
| SCD-R | CAGCGTAACGGAGAAAGGTG | |
| FAS | FAS-F | TGCTGTGCAACTATGCCCTA |
| FAS-R | CAGGTGAGGAAGGTGACAGT | |
| HSL | HSL-F | ATCTCCAGCGGACTGGTGTC |
| HSL-R | GCACCTGGATCTCGGTGATA | |
| ADPN | ADPN-F | TGGAGAAGGGTGACCAAGTC |
| ADPN-R | AAGGAGGAGTCATGGACGTT | |
| FoxO1 | FoxO1-F | GTGACATCATGACGCCAGTC |
| FoxO1-R | GATGTTGACTGAGCGTGTCC | |
| Actin | Actin-F | TACAATGTGGCCGAGGACTT |
| Actin-R | GAGAGAAGGAGGGTGGCTTT |
FABP3, Fatty acid binding protein 3; ACSL1, Long-chain acyl-CoA synthetase 1; SCD, stearoyl-CoA desaturase; FAS, Fatty acid synthase; HSL, Hormone sensitive lipase; ADPN, Adiponectin; and FoxO1, Forkhead transcription factor 1.
Effects of puerarin on the blood biochemical characteristics in beef cattle under hot environment.
| Item | Groups | ||||
| Control | Pue200 | Pue400 | Pue800 | ||
| INS (uIU/ml) | 16.02 ± 1.32 | 16.57 ± 1.32 | 14.89 ± 2.59 | 12.69 ± 1.47 | 0.435 |
| T3 (ng/ml) | 1.36 ± 0.07 | 1.33 ± 0.10 | 1.20 ± 0.07 | 1.16 ± 0.16 | 0.507 |
| T4 (ng/ml) | 51.35 ± 3.42 | 50.69 ± 3.17 | 47.88 ± 1.09 | 48.51 ± 2.12 | 0.749 |
| COR (ng/ml) | 48.54 ± 1.72 | 51.59 ± 2.59 | 45.83 ± 1.33 | 49.43 ± 1.39 | 0.056 |
| ADPN (mg/L) | 14.92 ± 1.38 | 15.28 ± 1.68 | 14.51 ± 0.89 | 14.37 ± 1.03 | 0.561 |
| LEP (ng/ml) | 10.36 ± 0.28 | 9.46 ± 0.70 | 6.91 ± 0.36 | 5.64 ± 0.36 | <0.001 |
| TC(mmol/L) | 4.44 ± 0.15 | 3.68 ± 0.28 | 4.26 ± 0.22 | 4.54 ± 0.21 | 0.048 |
| TG (mmol/L) | 0.34 ± 0.05 | 0.34 ± 0.03 | 0.29 ± 0.03 | 0.35 ± 0.04 | 0.638 |
| HDL-C(mmol/L) | 2.46 ± 0.28 | 2.20 ± 0.24 | 2.67 ± 0.24 | 2.58 ± 0.19 | 0.545 |
| LDL-C(mmol/L) | 0.78 ± 0.13 | 0.70 ± 0.12 | 0.69 ± 0.10 | 0.87 ± 0.16 | 0.751 |
Effect of Puerarin on the nutritional components of muscle in beef cattle under heat stress.
| Item | Groups | |||
| Control | Pue400 | Pue800 | ||
| Moisture/% | 71.55 ± 1.38 | 67.50 ± 2.74 | 70.68 ± 0.88 | 0.225 |
| Crude protein/% | 20.27 ± 0.43 | 19.54 ± 0.54 | 23.81 ± 0.15 | 0.039 |
| Crude fat/% | 4.31 ± 0.40 | 4.67 ± 0.52 | 5.20 ± 0.32 | 0.025 |
| Crude ash/% | 4.14 ± 0.16 | 3.87 ± 0.52 | 4.15 ± 0.23 | 0.234 |
| Ca,mmol/g | 0.58 ± 0.01 | 0.56 ± 0.006 | 0.57 ± 0.005 | 0.367 |
| P,mmol/g | 0.98 ± 0.13 | 0.87 ± 0.08 | 0.85 ± 0.01 | 0.554 |
Effects of Puerarin on fatty acid composition of longissimus thoracis muscle beef under heat stress (%).
| Items | Groups | |||
| Control | Pue400 | Pue800 | ||
| C14:0 | 1.94 ± 0.16 | 2.63 ± 0.42 | 2.37 ± 0.34 | 0.370 |
| C14:1 | 0.48 ± 0.02 | 0.62 ± 0.03 | 0.56 ± 0.06 | 0.038 |
| C15:0 | 0.25 ± 0.04 | 0.22 ± 0.01 | 0.26 ± 0.01 | 0.263 |
| C16:0 | 20.92 ± 1.35 | 24.15 ± 1.17 | 23.93 ± 1.25 | 0.184 |
| C16:1 | 2.62 ± 0.21 | 2.88 ± 0.12 | 2.49 ± 0.20 | 0.079 |
| C17:0 | 0.62 ± 0.07 | 0.62 ± 0.02 | 0.69 ± 0.05 | 0.571 |
| C17:1 | 0.41 ± 0.01 | 0.51 ± 0.06 | 0.39 ± 0.04 | 0.020 |
| C18:0 | 17.00 ± 0.88 | 16.64 ± 0.72 | 18.21 ± 2.23 | 0.733 |
| C18:1n9t | 0.35 ± 0.05 | 0.37 ± 0.03 | 0.29 ± 0.02 | 0.278 |
| C18:1n9c | 38.81 ± 1.19 | 39.85 ± 1.25 | 36.75 ± 1.22 | 0.243 |
| C18:2n6t | 0.22 ± 0.02 | 0.19 ± 0.02 | 0.18 ± 0.00 | 0.412 |
| C18:2n6c | 2.95 ± 0.28 | 2.52 ± 0.34 | 2.84 ± 0.13 | 0.512 |
| C20:0 | 0.18 ± 0.01 | 0.15 ± 0.01 | 0.17 ± 0.01 | 0.126 |
| C20:1 | 0.24 ± 0.07 | 0.18 ± 0.03 | 0.19 ± 0.03 | 0.610 |
| C18:3n3 | 0.17 ± 0.02 | 0.14 ± 0.02 | 0.14 ± 0.01 | 0.544 |
| Other acids | 11.28 ± 1.52 | 8.29 ± 1.34 | 10.00 ± 0.14 | 0.220 |
FIGURE 1Effect of Puerarin on the activity of fat metabolizing enzymes in heat stressed beef cattle (n = 4). Control: dietary supplementation with 0 mg/kg Puerarin in the feed concentrate; Pue400: dietary supplementation with 400 mg/kg Puerarin in the feed concentrate; Pue800: dietary supplementation with 800 mg/kg Puerarin in the feed concentrate. HSL, hormone sensitive lipase (A); LPL, lipoprotein lipase (B); ACC, acetyl CoA carboxylase (C); FAS, fatty acid synthase (D). Means within a row with no common superscript differ significantly (P < 0.05).
Summary statistics for sequence quality and alignment information of eight longissimus thoracis muscle samples in two groups.
| Items | Sample name | |||||||
| C1 | C2 | C3 | C4 | Pue1 | Pue2 | Pue3 | Pue4 | |
| Raw reads | 48652354 | 48175450 | 49644444 | 50765412 | 52708852 | 59764926 | 45526386 | 52692342 |
| Clean reads | 48120844 | 47648332 | 49077762 | 50105526 | 52105286 | 58726390 | 44767384 | 51755462 |
| Valid Ratio% | 98.91 | 98.91 | 98.86 | 98.70 | 98.85 | 98.26 | 98.33 | 98.22 |
| Q30(%) | 94.87 | 94.91 | 94.91 | 94.56 | 94.87 | 93.16 | 93.73 | 93.53 |
| GC content(%) | 54.16 | 53.19 | 53.73 | 54.00 | 53.97 | 53.93 | 53.88 | 54.10 |
| Total reads | 48120844 | 47648332 | 49077762 | 50105526 | 52105286 | 58726390 | 44767384 | 51755462 |
| Reads Total mapped | 46336007 | 45862232 | 47212767 | 48232193 | 50036325 | 55815890 | 42614063 | 49308979 |
| Multiple mapped | 3273916 | 4078776 | 3636977 | 3706831 | 4449377 | 4900461 | 3691312 | 4408835 |
| Uniquely mapped | 43062091 | 41783456 | 43575790 | 44525362 | 45586948 | 50915429 | 38922751 | 44900144 |
| Mapping rate (%) | 96.29 | 96.25 | 96.20 | 96.26 | 96.03 | 95.04 | 95.19 | 95.27 |
C1, C2, C3, C4 were four samples of the Control group (dietary supplementation with 0 mg/kg Puerarin in the feed concentrate), and Pue1,Pue2,Pue3,Pue4 were four samples of the Pue400 group (dietary supplementation with 400 mg/kg Puerarin in the feed concentrate).
FIGURE 2Correlations of eight samples (n = 4). C1, C2, C3, C4 were four samples of the Control group (dietary supplementation with 0 mg/kg Puerarin in the feed concentrate), and Pue1, Pue2, Pue3, Pue4 were four samples of the Pue400 group (dietary supplementation with 400 mg/kg Puerarin in the feed concentrate). In the figure, the right and lower sides are the sample names, the left and upper sides are the sample clustering, and the different color squares represent the correlation of the two samples.
FIGURE 3Volcano plot of the differentially expressed genes between control and Puerarin groups of longissimus thoracis muscles (n = 4). Control: dietary supplementation with 0 mg/kg Puerarin in the feed concentrate; Puerarin: dietary supplementation with 400 mg/kg Puerarin in the feed concentrate. The red dots represent the up-regulated DEGs, the green dots represent the down-regulated DEGs and the blue dots represent non-DEGs.
FIGURE 4Gene ontology (GO) annotation of differentially expressed genes.
Differentially expressed genes related to lipid metabolism.
| Gene ID | Gene name | Control |
| Expression trend | |
| Gene18657 | FATP5 | 0.85 | 1.83 | 2.14E−07 | UP |
| Gene4568 | CD36 | 0.44 | 0.97 | 1.36E−02 | UP |
| Gene1326 | FABP3 | 294.41 | 822.62 | 1.39E−03 | UP |
| Gene9621 | FABP7 | 0.69 | 1.83 | 1.15E−02 | UP |
| Gene24921 | ACSL1 | 52.49 | 113.48 | 2.03E−03 | UP |
| Gene18229 | Gadd45G/ | 1.84 | 4.09 | 3.73E−04 | UP |
| Gene24505 | SCD | 3.67 | 27.35 | 1.98E−05 | UP |
| Gene24080 | IRS3 | 0.03 | 0.78 | 7.40E−06 | UP |
| Gene19867 | FAS | 6.90 | 15.79 | 2.24E−06 | UP |
| Gene17954 | HSL | 11.4 | 2.97 | 1.86E−03 | DOWN |
| Gene7009 | ACOX3 | 14.02 | 3.62 | 2.85E−04 | DOWN |
| Gene470 | ADPN | 89.61 | 4.20 | 5.73E−07 | DOWN |
| Gene4212 | LEP | 0.42 | 0.02 | 4.98E−07 | DOWN |
| Gene14329 | ADCY8 | 0.03 | 0.11 | 3.14E−02 | UP |
| Gene16089 | PIK3CD | 0.45 | 0.94 | 2.79E−05 | UP |
| Gene4517 | PIK3CG | 0.52 | 1.33 | 1.81E−03 | UP |
| Gene6887 | PRKG2 | 0.33 | 0.83 | 4.50E−04 | UP |
| Gene12812 | FoxO1 | 14.23 | 6.57 | 3.12E−03 | DOWN |
| Gene6918 | MAPK10 | 0.02 | 0.80 | 1.81E−02 | UP |
| Gene19063 | CAMKK1 | 0.21 | 0.50 | 2.38E−02 | UP |
Control: dietary supplementation with 0 mg/kg Puerarin in the feed concentrate; Puerarin: dietary supplementation with 400 mg/kg Puerarin in the feed concentrate. FATP5, Fatty acid transporter protein 5; CD36, Fatty acid transposase; FABP, Fatty acid binding protein; ACSL1, Long-chain acyl-CoA synthetase 1; Gadd45G/, Growth arrest and DNA Damage-inducible Protein GADD45 gamma; SCD, stearoyl-CoA desaturase; IRS3, Insulin receptor substrate 3; FAS, Fatty acid synthase; HSL, Hormone sensitive lipase; ACOX3, Acyl-CoA oxidase 3; ADPN, Adiponectin; LEP, Leptin; ADCY8, Adenylate cyclase 8; PIK3CD, Phosphoinositide-3-kinase catalytic delta polypeptide; PIK3CG, Phosphoinositide-3-kinase catalytic gamma polypeptide; PRKG2, Protein kinase cGMP-dependent type II; FoxO1, Forkhead transcription factor 1; MAPK10, Mitogen activated protein kinase 10; and CAMKK1, Calcium/calmodulin dependent protein kin 1.
FIGURE 5Comparing analysis of relative gene expression in Control and Puerarin group (n = 4). Control: dietary supplementation with 0 mg/kg Puerarin in the feed concentrate; Puerarin: dietary supplementation with 400 mg/kg Puerarin in the feed concentrate. FABP3, Fatty acid binding protein 3; ACSL1, Long-chain acyl-CoA synthetase 1; SCD, stearoyl-CoA desaturase; FAS, Fatty acid synthase; HSL, Hormone sensitive lipase; ADPN, Adiponectin; and FoxO1, Forkhead transcription factor 1.
Classification of DEG according to the KEGG pathways enrichment analysis.
| Pathway name | Input number | Background number | |
| PPAR signaling pathway | 17 | 93 | 7.73E−07 |
| AMPK signaling pathway | 18 | 150 | 7.22E−05 |
| Regulation of lipolysis in adipocytes | 12 | 65 | 7.57E−05 |
| Insulin resistance | 15 | 125 | 4.48E−04 |
| Natural killer cell-mediated cytotoxicity | 20 | 221 | 8.69E−04 |
| Adipocytokine signaling pathway | 11 | 79 | 1.26E−03 |
| Phagosome | 19 | 225 | 2.61E−03 |
| Neuroactive ligand-receptor interaction | 25 | 364 | 5.19E−03 |
| Type II diabetes mellitus | 8 | 53 | 5.36E−03 |
| Kaposi sarcoma-associated herpesvirus infection | 20 | 263 | 5.54E−03 |
| Breast cancer | 15 | 176 | 8.64E−03 |
| Cellular senescence | 17 | 217 | 8.85E−03 |
| Human T-cell leukemia virus 1 infection | 24 | 389 | 1.63E−02 |
| Estrogen signaling pathway | 13 | 154 | 1.69E−02 |
| Viral carcinogenesis | 20 | 298 | 1.77E−02 |
| FoxO signaling pathway | 13 | 153 | 1.84E−02 |
| Influenza A | 16 | 228 | 2.64E−02 |
| Hepatitis C | 16 | 226 | 2.69E−02 |
| C-type lectin receptor signaling pathway | 10 | 108 | 2.71E−02 |
| Endocrine resistance | 10 | 110 | 2.80E−02 |